Seric Molecular Markers Correlated with Stroke Rehabilitation Outcomes: A Narrative Review
Authors:
Open Access
Abstract
An increasing number of stroke survivors are burdened by persistent disabilities, requiring long-term rehabilitation. However, the extent of functional gain is highly variable, severely impairing patients’ quality of life. This variability highlights a critical gap in current prognostic tools, which rely primarily on clinical and neuroimaging data. The aim of this review is to synthesize the current literature on serum biomarkers in stroke survivors and to evaluate their prognostic value for rehabilitation outcomes. Our synthesis indicates that biomarkers reflecting distinct pathophysiological processes are emerging as key prognostic indicators. Markers of inflammation such as Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 beta (IL-1β), and neuro-glial injury, including S100 Calcium-Binding Protein B (S100B), Neuron-Specific Enolase (NSE), Glial Fibrillary Acidic Protein (GFAP), and Neurofilament Light Chain (NfL), are consistently associated with poorer functional outcomes. Conversely, markers of neuroplasticity, such as Brain-Derived Neurotrophic Factor (BDNF) and Insulin-like Growth Factor-1 (IGF-1), serve as potential indicators of recovery potential, although their predictive accuracy remains inconsistent across studies. Furthermore, emerging biomarkers of synaptic activity, such as Syntaxin-1a (STX1A) and Synaptosomal-Associated Protein, 25kDa (SNAP-25), and neuromuscular junction integrity, such as C-terminal Agrin Fragment (CAF), offer novel insights into brain–periphery communication, though their clinical utility is still under investigation. While promising, the translation of these biomarkers into clinical practice is hindered by methodological limitations, including assay heterogeneity and lack of large-scale validation. Future standardization of these molecular signatures is a critical step toward implementing precision medicine in stroke rehabilitation.Keywords
Funding Information
- Universitatea de Medicină şi Farmacie "Carol Davila" Bucureşti
This publication has 145 references indexed in Scilit:
- C‐Terminal Agrin Fragment as a Biomarker for Sarcopenia: A Systematic Review and Meta‐AnalysisJournal of Cachexia, Sarcopenia and Muscle, 2025
- C‐terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative reviewJournal of Cachexia, Sarcopenia and Muscle, 2023
- The ENIGMA Stroke Recovery Working Group: Big data neuroimaging to study brain–behavior relationships after strokeHuman Brain Mapping, 2020
- Clinical Use of the Calcium-Binding S100B Protein, a Biomarker for Head Injury2019
- PREP2: A biomarker‐based algorithm for predicting upper limb function after strokeAnnals of Clinical and Translational Neurology, 2017
- Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitationJournal of Cachexia, Sarcopenia and Muscle, 2015
- Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and UtilizationClinical Pharmacology & Therapeutics, 2015
- S100B protects LAN‐5 neuroblastoma cells against Aβ amyloid‐induced neurotoxicity via RAGE engagement at low doses but increases Aβ amyloid neurotoxicity at high dosesJournal of Neuroscience Research, 2006
- Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery InfarctionArchives of Neurology, 2005
- Role of insulin‐like growth factor binding protein‐3 (IGFBP‐3) in the differentiation of primary human adult skeletal myoblastsJournal of Cellular Physiology, 2003